Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism

Gastroenterology(2021)10.1053/j.gastro.2021.09.066Source: DataRank Database

Activating Immune Recognition in Pancreatic Ductal Adenocarcinoma via Autophagy Inhibition, MEK Blockade, and CD40 Agonism is a research paper published in Gastroenterology (2021). On theSindex it has a DataRank of 0. It has been cited 40 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

40 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (15 grants)Impact (FWCI 2.28)OA: closedTopics (71)IDs (PubMed, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (7)

Tristan Courau ORCID,Joseph Borison,Alexa J. Ritchie,Aaron T. Mayer ORCID,Matthew F. Krummel ORCID

Live enrichment

PubMed:34627860 OpenAlex:https://openalex.org/W3204628173

National Cancer Institute

Grant: CA178015

National Cancer Institute

Grant: CA210974

National Cancer Institute

Grant: CA222862

National Cancer Institute

Grant: CA224081

National Cancer Institute

Grant: CA227807

National Cancer Institute

Grant: CA230263

National Cancer Institute

Grant: CA239604

NCI NIH HHS

Grant: R01 CA178015

NCI NIH HHS

Grant: R01 CA230263

NCI NIH HHS

Grant: U54 CA224081

NCI NIH HHS

Grant: R01 CA222862

NCI NIH HHS

Grant: R01 CA227807

NCI NIH HHS

Grant: R01 CA239604

NCI NIH HHS

Grant: U24 CA210974

National Institutes of Health

FWCI

2.28

Citation Percentile

0.9%

Citation Trend

2021

2022

2023

2024

2025

2026

closedLicense: https://www.elsevier.com/tdm/userlicense/1.0/

publisherhttps://api.elsevier.com/content/article/PII:S0016508521036180?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0016508521036180?httpAccept=text/plain

journalhttps://doi.org/10.1053/j.gastro.2021.09.066

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34627860

Fields of Study

interferon and immune responsesImmune cells in cancerAutophagy in Disease and TherapyAnimalsAutophagyAzetidinesCD40 AntigensCarcinoma, Pancreatic DuctalCell Line, TumorDrug SynergismHumansHydroxychloroquineImmunotherapyInterferon Type IMAP Kinase Kinase 1MAP Kinase Kinase 2MacrophagesMefloquineMembrane ProteinsMicePancreatic NeoplasmsParacrine CommunicationPiperidinesProtein Kinase InhibitorsTumor EscapeTumor MicroenvironmentTumor-Associated MacrophagesSTING Protein

MeSH Terms

Tumor-Associated MacrophagesSTING ProteinAnimalsAutophagyAzetidinesDrug SynergismHumansHydroxychloroquineImmunotherapyInterferon Type IMacrophagesMembrane ProteinsPancreatic NeoplasmsPiperidinesMefloquineCD40 AntigensTumor EscapeParacrine CommunicationCarcinoma, Pancreatic DuctalCell Line, TumorProtein Kinase InhibitorsMAP Kinase Kinase 1MAP Kinase Kinase 2MiceTumor Microenvironment

Keywords

AutophagyTumor microenvironmentCancer researchPancreatic cancerImmune systemImmunotherapyCancer immunotherapyPancreatic tumorMedicineBiologyImmunologyCancerApoptosisInternal medicinePancreatic Ductal AdenocarcinomaMapk PathwayMacrophage PolarizationCd40 Agonism

Sustainable Development Goals

SDG 0: Good health and well-being